Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Max Healthcare Institute Ltd.
NSE: MAXHEALTH
|
BSE: 543220
|
ISIN: INE027H01010
|
Industry: Healthcare Facilities
Capex Approval
|
Expensive Performer
1006.6500
-16.60
(
-1.62
%)
NSE
May 25, 2026
10:24 AM
Volume:
768.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Max Healthcare Institute Ltd.
04 Feb 2025
Capex Approval
1006.65
-1.62%
Max Healthcare | Q3FY25 Result Update
Buy:
Max Healthcare Institute Ltd.
by
Edelweiss
Target: 1320
Target
Edelweiss
Bed expansion to bolster growth
Max Healthcare Institute Ltd. is trading
above its 50 day SMA
of 999.8
More from Max Healthcare Institute Ltd.
All Rapid Results
Recommended
Market opens higher, Anupam Rasayan to acquire a Rs 1,370 crore stake in Bliss GSV Pharma
Trendlyne Marketwatch |
25 May 2026, 10:14AM
Five Interesting Stocks Today - May 22, 2026
The Baseline |
22 May 2026
US homebuyers waited out the frenzy, but there's no relief in sight
The Baseline US |
22 May 2026